Monash IVF Group Limited (MVF.AX)
AUD 1.08
(3.86%)
AUD 1.08
(3.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 59.56 Million AUD | 53.26% |
| 2023 | 38.86 Million AUD | 298.05% |
| 2022 | 9.76 Million AUD | -74.65% |
| 2021 | 38.51 Million AUD | 103.34% |
| 2020 | 18.94 Million AUD | -78.79% |
| 2019 | 89.29 Million AUD | -8.99% |
| 2018 | 98.1 Million AUD | 2.43% |
| 2017 | 95.77 Million AUD | 1.3% |
| 2016 | 94.54 Million AUD | -11.02% |
| 2015 | 106.26 Million AUD | 11.28% |
| 2014 | 95.48 Million AUD | -47.31% |
| 2013 | 181.21 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 59.56 Million AUD | 0.0% |
| 2024 FY | 59.56 Million AUD | 53.26% |
| 2024 Q2 | 72 Million AUD | -100.0% |
| 2023 Q4 | 38.86 Million AUD | 44.56% |
| 2023 Q2 | 26.88 Million AUD | 175.36% |
| 2023 FY | 38.86 Million AUD | 298.05% |
| 2022 Q4 | 9.76 Million AUD | 248.47% |
| 2022 Q2 | 2.8 Million AUD | -92.73% |
| 2022 FY | 9.76 Million AUD | -74.65% |
| 2021 Q2 | 6.99 Million AUD | -63.1% |
| 2021 Q4 | 38.51 Million AUD | 451.06% |
| 2021 FY | 38.51 Million AUD | 103.34% |
| 2020 FY | 18.94 Million AUD | -78.79% |
| 2020 Q2 | 96 Million AUD | 7.52% |
| 2020 Q4 | 18.94 Million AUD | -80.27% |
| 2019 FY | 89.29 Million AUD | -8.99% |
| 2019 Q2 | 93.12 Million AUD | -5.08% |
| 2019 Q4 | 89.29 Million AUD | -4.11% |
| 2018 Q2 | 100.06 Million AUD | 4.48% |
| 2018 FY | 98.1 Million AUD | 2.43% |
| 2018 Q4 | 98.1 Million AUD | -1.96% |
| 2017 FY | 95.77 Million AUD | 1.3% |
| 2017 Q4 | 95.77 Million AUD | -0.85% |
| 2017 Q2 | 96.59 Million AUD | 2.17% |
| 2016 FY | 94.54 Million AUD | -11.02% |
| 2016 Q4 | 94.54 Million AUD | -8.56% |
| 2016 Q2 | 103.39 Million AUD | -2.69% |
| 2015 Q4 | 106.26 Million AUD | 19.07% |
| 2015 FY | 106.26 Million AUD | 11.28% |
| 2015 Q2 | 89.24 Million AUD | -6.54% |
| 2014 Q2 | 195.14 Million AUD | 7.68% |
| 2014 FY | 95.48 Million AUD | -47.31% |
| 2014 Q4 | 95.48 Million AUD | -51.07% |
| 2013 FY | 181.21 Million AUD | 0.0% |
| 2013 Q4 | 181.21 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 55.06 Million AUD | -8.174% |
| BCAL Diagnostics Limited | 400.22 Thousand AUD | -14783.027% |
| Genetic Signatures Limited | - AUD | -Infinity% |
| Genetic Technologies Limited | - AUD | -Infinity% |
| Healius Limited | 420.8 Million AUD | 85.845% |
| Imagion Biosystems Limited | 750 Thousand AUD | -7842.0% |
| Integral Diagnostics Limited | 219.75 Million AUD | 72.895% |
| INOVIQ Ltd | - AUD | -Infinity% |
| Microba Life Sciences Limited | - AUD | -Infinity% |
| Rhythm Biosciences Limited | - AUD | -Infinity% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 97.786% |